The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys
- PMID: 12830306
- PMCID: PMC6878531
- DOI: 10.1002/mpr.138
The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys
Erratum in
- Int J Methods Psychiatr Res. 2003;12(3):165
Abstract
Absence of a common diagnostic interview has hampered cross-national syntheses of epidemiological evidence on major depressive episodes (MDE). Community epidemiological surveys using the World Health Organization Composite International Diagnostic Interview administered face-to-face were carried out in 10 countries in North America (Canada and the US), Latin America (Brazil, Chile, and Mexico), Europe (Czech Republic, Germany, the Netherlands, and Turkey), and Asia (Japan). The total sample size was more than 37,000. Lifetime prevalence estimates of hierarchy-free DSM-III-R/DSM-IV MDE varied widely, from 3% in Japan to 16.9% in the US, with the majority in the range of 8% to 12%. The 12-month/lifetime prevalence ratio was in the range 40% to 55%, the 30-day/12-month prevalence ratio in the range 45% to 65%, and median age of onset in the range 20 to 25 in most countries. Consistent socio-demographic correlates included being female and unmarried. Respondents in recent cohorts reported higher lifetime prevalence, but lower persistence than those in earlier cohorts. Major depressive episodes were found to be strongly co-morbid with, and temporally secondary to, anxiety disorders in all countries, with primary panic and generalized anxiety disorders the most powerful predictors of the first onset of secondary MDE. Major depressive episodes are a commonly occurring disorder that usually has a chronic-intermittent course. Effectiveness trials are needed to evaluate the impact of early detection and treatment on the course of MDE as well as to evaluate whether timely treatment of primary anxiety disorders would reduce the subsequent onset, persistence, and severity of secondary MDE.
Similar articles
-
Cross-national comparisons of the prevalences and correlates of mental disorders. WHO International Consortium in Psychiatric Epidemiology.Bull World Health Organ. 2000;78(4):413-26. Bull World Health Organ. 2000. PMID: 10885160 Free PMC article.
-
The epidemiology of depression in metropolitan China.Psychol Med. 2009 May;39(5):735-47. doi: 10.1017/S0033291708004091. Epub 2008 Aug 20. Psychol Med. 2009. PMID: 18713484 Free PMC article.
-
Age differences in the prevalence and co-morbidity of DSM-IV major depressive episodes: results from the WHO World Mental Health Survey Initiative.Depress Anxiety. 2010 Apr;27(4):351-64. doi: 10.1002/da.20634. Depress Anxiety. 2010. PMID: 20037917 Free PMC article.
-
Age differences in major depression: results from the National Comorbidity Survey Replication (NCS-R).Psychol Med. 2010 Feb;40(2):225-37. doi: 10.1017/S0033291709990213. Epub 2009 Jun 17. Psychol Med. 2010. PMID: 19531277 Free PMC article.
-
Estudio epidemiológico de sucesos traumáticos, trastorno de estrés post-traumático y otros trastornos psiquiátricos en una muestra representativa de Chile.Salud Ment (Mex). 2009 Jan 1;32(2):145-153. Salud Ment (Mex). 2009. PMID: 21113425 Free PMC article. Spanish.
Cited by
-
Depression Predicts Global Functional Outcomes in Individuals at Clinical High Risk for Psychosis.Psychiatr Res Clin Pract. 2021 Nov 17;3(4):163-171. doi: 10.1176/appi.prcp.20210023. eCollection 2021 Winter. Psychiatr Res Clin Pract. 2021. PMID: 36101655 Free PMC article.
-
Patient centredness and the outcome of primary care consultations with patients with depression in areas of high and low socioeconomic deprivation.Br J Gen Pract. 2012 Aug;62(601):e576-81. doi: 10.3399/bjgp12X653633. Br J Gen Pract. 2012. PMID: 22867682 Free PMC article.
-
Prescription and indication trends of antidepressant drugs in the Netherlands between 1996 and 2012: a dynamic population-based study.Eur J Clin Pharmacol. 2015 Mar;71(3):369-75. doi: 10.1007/s00228-014-1803-x. Epub 2015 Jan 6. Eur J Clin Pharmacol. 2015. PMID: 25560052
-
Nutrition and depression at the forefront of progress.J Med Life. 2012 Dec 15;5(4):414-9. Epub 2012 Dec 25. J Med Life. 2012. PMID: 23346242 Free PMC article.
-
Age-Related Cognitive Decline and the Olfactory Identification Deficit Are Associated to Increased Level of Depression.Front Neurosci. 2021 Feb 22;15:599593. doi: 10.3389/fnins.2021.599593. eCollection 2021. Front Neurosci. 2021. PMID: 33692667 Free PMC article.
References
-
- Akiskal HS. The interface of chronic depression with personality and anxiety disorders. Psychopharmacol Bull 1984; 20: 393–8. - PubMed
-
- American Psychiatric Association . Diagnostic and statistical manual of mental disorders, 3 edn Washington DC: American Psychiatric Association, 1980.
-
- American Psychiatric Association . Diagnostic and statistical manual of mental disorders. 3 edn revised. Washington DC: American Psychiatric Association, 1987.
-
- American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4 edn. Washington DC: American Psychiatric Association, 1994.
-
- Andrade L, de Lolio C, Gentil V, et al. Lifetime prevalence of mental disorders in a catchment area in São Paulo, Brazil. Paper presented at: VII Congress of the International Federation of Psychiatric Epidemiology Santiago, Chile, August 1996.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources